Download free ET iPad add for easier viewing of latest and financial News ! The expiry of patents on profitable heart medicines is soon going to erode one of the main sources of drug company profits, and risky bets on new medicines to replace them may not make up for the lost sales.
FULL ARTICLE AT The Economic Times